Exiqon A/S Licesnse Locked Nucleic Acids for Sirna to Applied Biosciences Corporation
Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announces that it has granted a license to Applied Biosystems (NYSE:ABI), an Applera Corporation business, to use Exiqon’s proprietary Locked Nucleic Acids (LNA) in siRNA. The details of the financial terms of the license agreement
are not disclosed.